Back to Search Start Over

5.0 Use of antiretroviral therapy in pregnancy.

Source :
HIV Medicine; Sep2012 Supplement, Vol. 13, p103-112, 10p
Publication Year :
2012

Abstract

The article discusses the recommendations with regards to the use of antiretroviral therapy (ART) in pregnancy. Women conceiving on an effective HAART regimen should continue ART even if it contains efavirenz or does not contain zidovudine and conditions under which exceptions are there are included. The Antiretroviral Pregnancy Registry (APR) provides the best data on teratogenicity and first trimester ART exposure. The Writing Group recommends that efavirenz can be used during pregnancy.

Subjects

Subjects :
HUMAN abnormalities
COMMUNICABLE diseases
INFECTIOUS disease transmission
HIV infections
PREMATURE infants
LABOR (Obstetrics)
PREGNANCY complications
PROTEASE inhibitors
ANTIRETROVIRAL agents
HIGHLY active antiretroviral therapy
CD4 lymphocyte count

Details

Language :
English
ISSN :
14642662
Volume :
13
Database :
Complementary Index
Journal :
HIV Medicine
Publication Type :
Academic Journal
Accession number :
78110457
Full Text :
https://doi.org/10.1111/j.1468-1293.2012.1030_6.x
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details